Get started
Author

S. V. Saju

Observed names: S V Saju, S V. Saju, S. V. Saju*, S.V. Saju, Saju S V, Saju SV
ORCID: 0000-0003-0268-7937
Observed ORCID: 0000-0003-0268-7937
OpenAlex ID: A5060253604
Factors that impact the outcomes in testicular germ cell tumors in low–middle-income countries
2019 · S. V. Saju, Venkatraman Radhakrishnan, et al. · Medical Oncology · 32
Clinicopathologic Profile and Treatment Outcomes of Colorectal Cancer in Young Adults: A Multicenter Study From India
2024 · Amit Sehrawat, Mridul Khanna, et al. · JCO Global Oncology · 5
Analysis of extra-cranial germ cell tumors in male children: Experience from a single centre in India
2020 · Hemanth Kumar, S.V. Saju, et al. · Pediatric Hematology Oncology Journal · 5
Outcome of COVID-19 in Indian patients with cancer: A multicenter, retrospective study
2022 · Arun Seshachalam*, S. V. Saju*, et al. · Cancer Research Statistics and Treatment · 4
A Multicenter Study on the Challenges and Real-World Utilization of Immune Checkpoint Inhibitors in Resource-Constrained Settings: Insights and Implications from India
2024 · Ashwin Oommen Philips, Sunu Cyriac, et al. · South Asian Journal of Cancer · 3
PDF
Unveiling primary platinum resistant ovarian cancer: Demographic and clinical perspectives from multicenter cancer registry in India.
2024 · Lakhwinder Singh, Amit Sehrawat, et al. · Journal of Clinical Oncology · 2
PDF
Unveiling the challenges of small cell lung cancer in resource-limited settings: A multicenter collaboration analysis of demographics, treatment modalities, and prognosis.
2024 · Mayank Kapoor, Amit Sehrawat, et al. · Journal of Clinical Oncology · 2
56P Clinico-pathological profile of adolescent and young adult colorectal cancer patients: Multicentre collaborative registry data from India
2022 · S.S. Panda, A. Sehrawat, et al. · Annals of Oncology · 2
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rare Case Report with Literature Review
2021 · Nikita Oza, Krishnakumar Rathnam, et al. · Indian Journal of Medical and Paediatric Oncology · 2
PDF
Prognostic Significance of Molecular Profile in Non-metastatic Invasive Breast Cancer: A Multicentre Study from India
2020 · Krishnakumar Rathnam, K. Niraimathi, et al. · Indian Journal of Gynecologic Oncology · 2
Primary Platinum-Resistant Ovarian Cancer: Clinicopathologic Correlates and Outcomes From a Multicenter Prospective Indian Registry
2026 · Amit Sehrawat, Lakhwinder Singh, et al. · JCO Global Oncology · 1
Real-World Experiences of Next-Generation Sequencing in Oncology: From an Indian Multicenter Registry and Collaborative Centers
2024 · Ashwin Oommen Philips, Soumya Surath Panda, et al. · Indian Journal of Medical and Paediatric Oncology · 1
PDF
Real-World Data on Treatment Outcome of ALK-Positive Non-Small Cell Lung Cancer from an Indian Multicentric Cancer Registry
2023 · Lalatendu Moharana, Soumya Surath Panda, et al. · South Asian Journal of Cancer · 1
PDF
Adolescent and Young Adults with Gastric Cancer (AYA-GC)—The Dilemma of an Under-Represented Group: A Multi-Institutional Analysis from the Indian Subcontinent
2023 · Soumya Surath Panda, Swati Sucharita Mohanty, et al. · South Asian Journal of Cancer · 1
PDF
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
2022 · Krishnakumar Rathnam, S. V. Saju, et al. · Indian Journal of Medical and Paediatric Oncology · 1
PDF
Real-world efficacy and safety of trastuzumab emtansine biosimilar (UJVIRA®) in early and metastatic HER2-positive breast cancer: a multicenter pooled retrospective analysis from India
2026 · Ayesha Mahajan, Soumya Surath Panda, et al. · Breast Cancer Research and Treatment
81P Impact of FIGO 2023 staging and molecular classification on stage migration and adjuvant treatment decisions in endometrial cancer: Results from a multicentric prospective Indian cohort (MECASIS)
2026 · A.O. Philips, R. B, et al. · ESMO Open
PDF
The AI paradox in precision oncology: Prospective blinded validation of large language models against molecular tumor board.
2026 · Arun Seshachalam, K Niraimathi Anandan, et al. · Journal of Clinical Oncology
PDF
27eP Real-world efficacy and safety of trastuzumab emtansine (T-DM1 Biosimilar, Ujvira) in early and metastatic HER2-positive breast cancer: A multicentre pooled retrospective analysis from India
2026 · S.S. Panda, A. Mahajan, et al. · ESMO Open
PDF
Clinicopathological Profile and Survival Outcomes of Her-2 Low versus Her-2 Negative subsets of Breast Cancer from a Tertiary Care Center in South India
2026 · Honey Susan Raju, S. V. Saju, et al. · Indian Journal of Medical and Paediatric Oncology
Lung Cancer in Adolescent and Young Adults: Unveiling Challenges and Outcomes—A Report from the Network of Oncology Clinical Trials India
2026 · A. Philips, A. Sehrawat, et al. · Indian Journal of Medical and Paediatric Oncology
Exploring the New Cancer Care Vital Signs in Geriatric Oncology—An Institutional Pilot Study
2026 · R. K. Pothamsetty, K. K. Rathnam, et al. · Indian Journal of Medical and Paediatric Oncology
DPyD Polymorphism: Are Indians Different? A Single-Center Experience
2026 · Honey Susan Raju, Krishnakumar Rathnam, et al. · Indian Journal of Medical and Paediatric Oncology
Multi-Institutional Study on Breast Cancer Among Adolescent and Young Adults in NOCI Affiliated Centers Across India
2026 · M. Manikandan, S. V. Saju, et al. · Indian Journal of Medical and Paediatric Oncology
822MO Efficacy of anti-emetic therapy in highly emetogenic chemotherapy-induced nausea and vomiting in breast cancer patients: A prospective observational study from a tertiary care centre
2025 · S.V. Saju, H.S. Raju, et al. · Annals of Oncology
Works count: 33
Citation count: 63
H-index: 4
I10-index: 1
Year
Topic
Type